Medicine recalls
|
| |
| Canada: Recall: Ruzurgi Tablet 10mg |
| |
Health Canada announces that Medunik Canada is recalling one lot of Ruzurgi Tablet 10mg (amifampridine) (lot number: 18038) from wholesalers, retailers and end users because total combinated yeasts and molds count (TYMC) is out of specification in the affected lot.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../76465r-eng.php
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by the United States Food and Drug Administration, and was posted on the Drug Office website on 14 Sep 2021.
Ends/Tuesday, Sep 21, 2021
Issued at HKT 14:00
|
| |
|
